Adalimumab treatment for SAPHO syndrome

Acta Derm Venereol. 2010 May;90(3):301-2. doi: 10.2340/00015555-0822.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acquired Hyperostosis Syndrome / diagnosis
  • Acquired Hyperostosis Syndrome / drug therapy*
  • Adalimumab
  • Anti-Inflammatory Agents / therapeutic use*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Female
  • Humans
  • Infliximab
  • Middle Aged
  • Steroids / therapeutic use
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Steroids
  • Infliximab
  • Adalimumab